The global no-invasive sphygmomanometer market is expected to grow at a CAGR of 5.5% during the forecast period, from 2021 to 2030. The growth of this market can be attributed to the increasing number of patients suffering from hypertension and other cardiovascular diseases, which are major causes for stroke and heart attack. The increasing awareness about the benefits of no-invasive sphygmomanometers over invasive ones is also driving the growth of this market.
The global no-invasive sphygmomanometer market has been segmented on the basis of type, application, and region. On the basis of type, it has been classified into automatic sphygmomanometer, mercury sphygmomanometer, and aneroid sphygmomanometer. On the basis of application, it has been classified into hospitals & clinics and home care settings. On the basis of region it has been classified into North America (US, Canada), Latin America (Mexico), Europe (Germany), Asia Pacific (China) & Middle East & Africa (Saudi Arabia).
Some Of The Growth Factors Of This Market:
- The increasing number of people suffering from hypertension and other cardiovascular diseases is driving the growth of the non-invasive sphygmomanometer market.
- The rising awareness about the benefits of non-invasive sphygmomanometers over invasive ones is also driving the growth of this market.
- The increasing number of hospitals and clinics using non-invasive sphygmomanometers for diagnosis and treatment is also a factor that drives this market's growth.
- The growing demand for home healthcare products, such as blood pressure monitors, is another factor that drives this market's growth.
- Increasing government initiatives to promote healthy living are also a factor that drives this market's growth.
Industry Growth Insights published a new data on “Non-Invasive Sphygmomanometer Market”. The research report is titled “Non-Invasive Sphygmomanometer Market research by Types (Automatic Sphygmomanometer, Mercury Sphygmomanometer, Aneroid Sphygmomanometer), By Applications (Hospitals, Clinics, Home Care, Others), By Players/Companies Omron Healthcare, Compumedics, Briggs Healthcare, Abbott Laboratories, Siemens Healthcare, Nihon Kohden, GE Healthcare, A&D Medical, Conmed, Covidien, Yuwell”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Non-Invasive Sphygmomanometer Market Research Report
By Type
Automatic Sphygmomanometer, Mercury Sphygmomanometer, Aneroid Sphygmomanometer
By Application
Hospitals, Clinics, Home Care, Others
By Companies
Omron Healthcare, Compumedics, Briggs Healthcare, Abbott Laboratories, Siemens Healthcare, Nihon Kohden, GE Healthcare, A&D Medical, Conmed, Covidien, Yuwell
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
234
Number of Tables & Figures
164
Customization Available
Yes, the report can be customized as per your need.
Global Non-Invasive Sphygmomanometer Market Report Segments:
The global Non-Invasive Sphygmomanometer market is segmented on the basis of:
Types
Automatic Sphygmomanometer, Mercury Sphygmomanometer, Aneroid Sphygmomanometer
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Clinics, Home Care, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Omron Healthcare
- Compumedics
- Briggs Healthcare
- Abbott Laboratories
- Siemens Healthcare
- Nihon Kohden
- GE Healthcare
- A&D Medical
- Conmed
- Covidien
- Yuwell
Highlights of The Non-Invasive Sphygmomanometer Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Automatic Sphygmomanometer
- Mercury Sphygmomanometer
- Aneroid Sphygmomanometer
- By Application:
- Hospitals
- Clinics
- Home Care
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Non-Invasive Sphygmomanometer Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
A non-invasive sphygmomanometer is a medical device that measures the pressure in a person's blood vessels.
Some of the key players operating in the non-invasive sphygmomanometer market are Omron Healthcare, Compumedics, Briggs Healthcare, Abbott Laboratories, Siemens Healthcare, Nihon Kohden, GE Healthcare, A&D Medical, Conmed, Covidien, Yuwell.
The non-invasive sphygmomanometer market is expected to register a CAGR of 5.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Non-Invasive Sphygmomanometer Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Non-Invasive Sphygmomanometer Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Non-Invasive Sphygmomanometer Market - Supply Chain
4.5. Global Non-Invasive Sphygmomanometer Market Forecast
4.5.1. Non-Invasive Sphygmomanometer Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Non-Invasive Sphygmomanometer Market Size (000 Units) and Y-o-Y Growth
4.5.3. Non-Invasive Sphygmomanometer Market Absolute $ Opportunity
5. Global Non-Invasive Sphygmomanometer Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Non-Invasive Sphygmomanometer Market Size and Volume Forecast by Type
5.3.1. Automatic Sphygmomanometer
5.3.2. Mercury Sphygmomanometer
5.3.3. Aneroid Sphygmomanometer
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Non-Invasive Sphygmomanometer Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Non-Invasive Sphygmomanometer Market Size and Volume Forecast by Application
6.3.1. Hospitals
6.3.2. Clinics
6.3.3. Home Care
6.3.4. Others
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Non-Invasive Sphygmomanometer Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Non-Invasive Sphygmomanometer Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Non-Invasive Sphygmomanometer Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Non-Invasive Sphygmomanometer Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Non-Invasive Sphygmomanometer Demand Share Forecast, 2019-2026
9. North America Non-Invasive Sphygmomanometer Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Non-Invasive Sphygmomanometer Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Non-Invasive Sphygmomanometer Market Size and Volume Forecast by Application
9.4.1. Hospitals
9.4.2. Clinics
9.4.3. Home Care
9.4.4. Others
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Non-Invasive Sphygmomanometer Market Size and Volume Forecast by Type
9.7.1. Automatic Sphygmomanometer
9.7.2. Mercury Sphygmomanometer
9.7.3. Aneroid Sphygmomanometer
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Non-Invasive Sphygmomanometer Demand Share Forecast, 2019-2026
10. Latin America Non-Invasive Sphygmomanometer Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Non-Invasive Sphygmomanometer Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Non-Invasive Sphygmomanometer Market Size and Volume Forecast by Application
10.4.1. Hospitals
10.4.2. Clinics
10.4.3. Home Care
10.4.4. Others
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Non-Invasive Sphygmomanometer Market Size and Volume Forecast by Type
10.7.1. Automatic Sphygmomanometer
10.7.2. Mercury Sphygmomanometer
10.7.3. Aneroid Sphygmomanometer
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Non-Invasive Sphygmomanometer Demand Share Forecast, 2019-2026
11. Europe Non-Invasive Sphygmomanometer Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Non-Invasive Sphygmomanometer Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Non-Invasive Sphygmomanometer Market Size and Volume Forecast by Application
11.4.1. Hospitals
11.4.2. Clinics
11.4.3. Home Care
11.4.4. Others
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Non-Invasive Sphygmomanometer Market Size and Volume Forecast by Type
11.7.1. Automatic Sphygmomanometer
11.7.2. Mercury Sphygmomanometer
11.7.3. Aneroid Sphygmomanometer
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Non-Invasive Sphygmomanometer Demand Share, 2019-2026
12. Asia Pacific Non-Invasive Sphygmomanometer Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Non-Invasive Sphygmomanometer Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Non-Invasive Sphygmomanometer Market Size and Volume Forecast by Application
12.4.1. Hospitals
12.4.2. Clinics
12.4.3. Home Care
12.4.4. Others
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Non-Invasive Sphygmomanometer Market Size and Volume Forecast by Type
12.7.1. Automatic Sphygmomanometer
12.7.2. Mercury Sphygmomanometer
12.7.3. Aneroid Sphygmomanometer
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Non-Invasive Sphygmomanometer Demand Share, 2019-2026
13. Middle East & Africa Non-Invasive Sphygmomanometer Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Non-Invasive Sphygmomanometer Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Non-Invasive Sphygmomanometer Market Size and Volume Forecast by Application
13.4.1. Hospitals
13.4.2. Clinics
13.4.3. Home Care
13.4.4. Others
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Non-Invasive Sphygmomanometer Market Size and Volume Forecast by Type
13.7.1. Automatic Sphygmomanometer
13.7.2. Mercury Sphygmomanometer
13.7.3. Aneroid Sphygmomanometer
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Non-Invasive Sphygmomanometer Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Non-Invasive Sphygmomanometer Market: Market Share Analysis
14.2. Non-Invasive Sphygmomanometer Distributors and Customers
14.3. Non-Invasive Sphygmomanometer Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Omron Healthcare
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Compumedics
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Briggs Healthcare
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Abbott Laboratories
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Siemens Healthcare
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Nihon Kohden
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. GE Healthcare
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. A&D Medical
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Conmed
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Covidien
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. Yuwell
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
